<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677166</url>
  </required_header>
  <id_info>
    <org_study_id>5200176</org_study_id>
    <nct_id>NCT04677166</nct_id>
  </id_info>
  <brief_title>Coupling Negative Pressure Wound Therapy With Instillation</brief_title>
  <official_title>Coupling Negative Pressure Wound Therapy With Instillation for Optimal Graft Take: Randomized Prospective Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Acelity</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare standard negative pressure wound therapy with&#xD;
      negative pressure wound therapy coupled with instillation for optimal skin graft take. Either&#xD;
      the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied&#xD;
      intra-operatively to split-thickness skin grafts of upper and lower extremity wounds and kept&#xD;
      in place for a duration of four days. Following completion of four days, the skin graft with&#xD;
      be assessed for percentage of take/adherence and will be covered with simple gauze dressings&#xD;
      as needed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Past studies have investigated the use of NPWT for post-operative skin graft treatment and&#xD;
      shown superior outcomes regarding graft take and need for repeat grafting when compared with&#xD;
      standard gauze dressing. However, to date, no study has compared standard NPWT to NPWT&#xD;
      coupled with instillation for post-operative treatment of extremity skin grafts. This study&#xD;
      is designed as a randomized, controlled pilot study to compare treatment standard NPWT with&#xD;
      NPWT coupled with instillation on skin graft take.&#xD;
&#xD;
      Patients will be selected based on inclusion criteria and randomized to either the treatment&#xD;
      (NPWT coupled with instillation) or the control group (standard NPWT). Depending on the group&#xD;
      to which they are randomized to, patients will have standard NPWT or NPWT coupled with&#xD;
      instillation applied intra-operatively after application of split thickness skin graft for&#xD;
      treatment of extremity wound.&#xD;
&#xD;
      Patients randomized to control group will receive V.A.C Ulta NPWT at 125mmHg continuous&#xD;
      pressure for duration of four days.&#xD;
&#xD;
      Patients randomized to treatment group will receive V.A.C VeraFlo therapy. Protocol will&#xD;
      consist of the following:&#xD;
&#xD;
        -  Instillation solution: normal saline&#xD;
&#xD;
        -  Dwell/soak time: 30 seconds&#xD;
&#xD;
        -  Cycle Time: 4 hours&#xD;
&#xD;
        -  Pressure: 125mmHg&#xD;
&#xD;
      The devices will be kept in place for four days, at which point, the wound vacs will be&#xD;
      removed and the percentage of skin graft take will be evaluated with use of photometric&#xD;
      analysis. The skin grafts will be subsequently dressed with gauze as appropriate. Patients&#xD;
      will be followed up in clinic to assess outcome of skin graft take.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 19, 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to either the treatment group (negative pressure wound therapy coupled with instillation) or the control group (standard negative pressure wound therapy). Both groups will receive four days of intervention and outcomes will be measured at day four of negative pressure wound therapy and at thirty days post-operatively.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Skin Graft Take at Four Days Post-Operative</measure>
    <time_frame>4 days from intervention</time_frame>
    <description>percentage of skin graft take at time of wound vac take down (4 days post-op)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Skin Graft Take at Thirty Days Post-Operative</measure>
    <time_frame>30 days from intervention</time_frame>
    <description>percentage of skin graft take at follow up clinic appointment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Wound</condition>
  <condition>Ulcer</condition>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>NPWT with Instillation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NPWT coupled with instillation will be employed via use of V.A.C. VeraFlo device. The protocol to be used is as follows:&#xD;
Instillation Solution: normal saline Dwell/Soak Time: 30 seconds Cycle Time: 4 hours Pressure: 125mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard NPWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard NPWT with use of V.A.C. Ulta device employed at 125mmHg continuous suction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative pressure wound therapy coupled with instillation</intervention_name>
    <description>Use of V.A.C. VeraFlo to treat skin grafts with NPWT coupled with instillation.</description>
    <arm_group_label>NPWT with Instillation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Negative Pressure Wound Therapy</intervention_name>
    <description>standard negative pressure wound therapy via V.A.C. Ulta device at 125mmHg suction.</description>
    <arm_group_label>Standard NPWT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have been offered split-thickness skin graft for treatment of an&#xD;
             extremity wound.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abnormal healing (diagnosed with connective tissue disorder)&#xD;
&#xD;
          -  Uncontrolled diabetes mellitus (HgbA1c &gt;9)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subhas W Gupta, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yin Y, Zhang R, Li S, Guo J, Hou Z, Zhang Y. Negative-pressure therapy versus conventional therapy on split-thickness skin graft: A systematic review and meta-analysis. Int J Surg. 2018 Feb;50:43-48. doi: 10.1016/j.ijsu.2017.12.020. Epub 2017 Dec 29. Review.</citation>
    <PMID>29292216</PMID>
  </reference>
  <reference>
    <citation>Nguyen TQ, Franczyk M, Lee JC, Greives MR, O'Connor A, Gottlieb LJ. Prospective randomized controlled trial comparing two methods of securing skin grafts using negative pressure wound therapy: vacuum-assisted closure and gauze suction. J Burn Care Res. 2015 Mar-Apr;36(2):324-8. doi: 10.1097/BCR.0000000000000089.</citation>
    <PMID>25162948</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

